Trastuzumab Injection: MedlinePlus Drug Information

ยาเคมีบำบัดสูตร Trastuzumab - Chulacancer รังสีรักษาและมะเร็งวิทยา trastuzumab

Trastuzumab is a humanized, recombinant monoclonal antibody that binds to the extracellular domain of HER2, MW: KD

trastuzumab Trastuzumab was developed by Genentech Inc as a recombinant humanized monoclonal antibody directed against the Trastuzumab side effects · heart problems; · nausea, diarrhea, weight loss; · headache; · trouble sleeping, feeling tired; · low blood cell The results of this trial indicate that trastuzumab is active as a single agent and produces durable objective responses in women with HER2-overexpressing

ufabuddy Key Message The ShortHER trial failed to demonstrate the non-inferiority of 9 weeks versus 1 year of adjuvant trastuzumab combined with chemotherapy The short